Molecular Detection Systems

Systems and reagents for nucleic acid detection and quantification in cell and gene therapy applications. Supports quality control and process monitoring in biopharmaceutical manufacturing.

Molecular detection devices and microfluidic systems for point-of-care and in vitro diagnostic testing. The company manufactures molecular detection components and related disposable consumables using precision molding, injection molding, laser processing, and assembly techniques. ISO 13485 certified for medical device production with capabilities spanning prototyping through large-scale manufacturing.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Microfluidic systems designed for sensitive detection and quantification of disease biomarkers in biological samples for diagnostic and monitoring purposes.

Molecular diagnostics platform for infectious disease identification and confirmation. Utilizes proprietary technology for rapid and accurate pathogen detection.

Point-of-care testing system for molecular detection applications. Enables rapid on-site diagnosis with molecular-level precision for clinical or field testing.

A portable point-of-care molecular detection system designed for rapid nucleic acid testing outside traditional laboratory environments. The solution enables on-site molecular diagnostics with minimal sample preparation.

Molecular reagent kits for nucleic acid detection and identification of microorganisms. Enables PCR-based and other molecular genetic methodologies for pathogen detection and characterization.

An advanced molecular medicine platform providing fast and precise detection of genetic markers and disease indicators. The technology addresses unmet clinical needs in genetic disease screening and diagnosis.

PCR-based detection solutions integrated within the company's rapid molecular diagnostic system. These enable amplification and identification of target nucleic acid sequences from stabilized clinical specimens.

Optimized enzyme components for nucleic acid amplification and detection in molecular diagnostics. Provides consistent performance in various assay formulations and detection platforms.

Integrated microfluidic platforms for molecular-level disease detection and pathogen identification. Combines sample preparation, amplification, and detection in a single miniaturized device for clinical diagnostics.